BE2016C017I2 - - Google Patents

Download PDF

Info

Publication number: BE2016C017I2
Authority: BE; Belgium
Prior art keywords: salmeterol; budesonide; solvate; component; salt
Prior art date: 2001-08-07

Application number

BE2016C017C

Other languages

English (en)

Original Assignee

Galephar M/F

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-08-07

Filing date

2016-04-06

Publication date

2021-07-19

2016-04-06 Application filed by Galephar M/F filed Critical Galephar M/F

2021-07-19 Publication of BE2016C017I2 publication Critical patent/BE2016C017I2/fr

Links

VOVIALXJUBGFJZ-KWVAZRHASA-N Budesonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1C[C@H]3OC(CCC)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O VOVIALXJUBGFJZ-KWVAZRHASA-N 0.000 abstract 3
GIIZNNXWQWCKIB-UHFFFAOYSA-N Serevent Chemical compound C1=C(O)C(CO)=CC(C(O)CNCCCCCCOCCCCC=2C=CC=CC=2)=C1 GIIZNNXWQWCKIB-UHFFFAOYSA-N 0.000 abstract 3
229960004436 budesonide Drugs 0.000 abstract 3
229960004017 salmeterol Drugs 0.000 abstract 3
150000003839 salts Chemical class 0.000 abstract 2
239000012453 solvate Substances 0.000 abstract 2
239000004480 active ingredient Substances 0.000 abstract 1
239000003937 drug carrier Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Otolaryngology (AREA)
Dispersion Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BE2016C017C 2001-08-07 2016-04-06 BE2016C017I2 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
BE0100132		2001-08-07
PCT/BE2002/000132 WO2003013547A1 (fr)	2001-08-07	2002-07-31	Composition pharmaceutique comprenant salmeterol et budesonide pour le traitement de troubles respiratoires

Publications (1)

Publication Number	Publication Date
BE2016C017I2 true BE2016C017I2 (fr)	2021-07-19

Family

ID=50036776

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE2016C017C BE2016C017I2 (fr)	2001-08-07	2016-04-06

Country Status (8)

Country	Link
US (2)	US20040247530A1 (fr)
EP (1)	EP1414468B1 (fr)
AT (1)	ATE284696T1 (fr)
BE (1)	BE2016C017I2 (fr)
CA (1)	CA2456721C (fr)
DE (1)	DE60202299T2 (fr)
ES (1)	ES2232769T3 (fr)
WO (1)	WO2003013547A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040191176A1 (en) *	2003-03-28	2004-09-30	Kaplan Leonard W	Formulations for treatment of pulmonary disorders
SE527069C2 (sv)	2003-06-19	2005-12-13	Mederio Ag	Förfarande och anordning för administrering av läkemedelspulver
MX2013000642A (es) *	2010-07-16	2013-04-03	Cipla Ltd	Composiciones farmaceuticas.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0009613D0 (en) *	2000-04-18	2000-06-07	Glaxo Group Ltd	Pharmaceutical compositions
AU2001278115A1 (en) *	2000-08-04	2002-02-18	Longwood Pharmaceutical Research, Inc.	Formulations of mometasone and a bronchodilator for pulmonary administration

2002
- 2002-07-31 DE DE60202299T patent/DE60202299T2/de not_active Expired - Lifetime
- 2002-07-31 US US10/486,217 patent/US20040247530A1/en not_active Abandoned
- 2002-07-31 AT AT02759940T patent/ATE284696T1/de not_active IP Right Cessation
- 2002-07-31 EP EP20020759940 patent/EP1414468B1/fr not_active Expired - Lifetime
- 2002-07-31 ES ES02759940T patent/ES2232769T3/es not_active Expired - Lifetime
- 2002-07-31 WO PCT/BE2002/000132 patent/WO2003013547A1/fr not_active Ceased
- 2002-07-31 CA CA2456721A patent/CA2456721C/fr not_active Expired - Lifetime
2007
- 2007-09-13 US US11/898,534 patent/US20080107740A1/en not_active Abandoned
2016
- 2016-04-06 BE BE2016C017C patent/BE2016C017I2/fr unknown

Also Published As

Publication number	Publication date
CA2456721C (fr)	2012-03-20
WO2003013547A1 (fr)	2003-02-20
DE60202299T2 (de)	2005-12-08
ATE284696T1 (de)	2005-01-15
ES2232769T3 (es)	2005-06-01
US20080107740A1 (en)	2008-05-08
EP1414468A1 (fr)	2004-05-06
US20040247530A1 (en)	2004-12-09
DE60202299D1 (de)	2005-01-20
CA2456721A1 (fr)	2003-02-20
EP1414468B1 (fr)	2004-12-15

Similar Documents

Publication	Publication Date	Title
AP1818A (en)	2008-01-07	Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
GEP20074208B (en)	2007-10-10	Substituted amides active at the cannabinoid-1 receptor
PL365783A1 (en)	2005-01-10	4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives
TR199500856A2 (tr)	1996-06-21	Nefesle ice cekilerek alinan farmasötik bilesim.
EP1283054A4 (fr)	2006-04-12	Medicaments permettant de traiter les complications du diabete et des neuropathies et utilisation de ces medicaments
CA2334411A1 (fr)	1999-12-16	Utilisation d'une composition comprenant du formoterol et du budesonide pour la prevention ou le traitement d'un etat aigu d'asthme
MXPA04004837A (es)	2004-08-02	Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
IL161154A0 (en)	2004-08-31	Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
CA2258095A1 (fr)	1998-08-13	Compositions contenant de la tetrahydrolipstatine
WO2002088100A3 (fr)	2003-05-30	3-piperidinopropiophenones dopees et produits pharmaceutiques contenant ces composes
WO2004030611A3 (fr)	2004-06-17	Inhibiteurs non nucleosidiques de transcriptases inverses
CA2386690A1 (fr)	2001-03-08	Sels pharmaceutiques de tramadol
MX2007015480A (es)	2008-04-29	Formulaciones de dosificacion solida de medicamentos narcoticos que tienen adsorcion bucal mejorada.
HK1042303A1 (zh)	2002-08-09	新的化合物
WO2002030467A3 (fr)	2002-10-24	Composition destinee a soigner des plaies, renfermant un compose actif du point de vue therapeutique, du miel notamment
WO1999061010A3 (fr)	2000-04-27	TRAITEMENT DE L'INFERTILITE PAR DES COMPOSES STIMULANT LA PRODUCTION D'AMPc, SEULS OU ASSOCIES A AU MOINS UN COMPOSE STIMULANT LA MEIOSE
CA2417935A1 (fr)	2002-02-14	Medicament anti-inflammatoire
AU2173101A (en)	2001-07-03	Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents
HK1042493A1 (zh)	2002-08-16	新的化合物
MXPA02011533A (es)	2003-04-25	Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
SE0000303D0 (sv)	2000-01-31	Novel compounds
MXPA04005033A (es)	2004-08-11	Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
MXPA02006034A (es)	2004-08-23	Formas de dosis mucosaloral de apomorfina.
ATE284696T1 (de)	2005-01-15	Pharmazeutische zusammensetzung enthaltend salmeterol und budesonid zur behandlung von atemkrankheiten
WO2004033484A3 (fr)	2004-06-10	Utilisation de derives stables de la glutamine aux fins d'amelioration de l'absorption medicamenteuse